期刊文献+

冠心病和非特异性炎症反应标志物相关性研究 被引量:1

The Relationship Between Coronary Heart Disease and C-reactive Protein,Fibrinogen and Interleukin-6
暂未订购
导出
摘要 冠心病的病理基础是动脉粥样硬化。炎症反应在动脉粥样硬化的发生发展中起着重要的作用,并且贯穿于动脉粥样硬化病变的发生,发展和恶化的全过程,并在一定程度上决定着动脉粥样硬化斑块的稳定性和自然进程。大量的研究发展检测血中C反应蛋白、纤维蛋白原、白细胞介素6等一些炎性标志物的水平可以预测心血管的危险性,提高传统危险评估的能力,并且具有潜在的指导治疗干预的能力。
出处 《心血管病学进展》 CAS 2005年第B08期70-74,共5页 Advances in Cardiovascular Diseases
  • 相关文献

参考文献29

  • 1Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis [ J ]. Circulation, 2002,105 ( 9 ) : 1135-1143.
  • 2Davies M. The pathophysiology of acute coronary syndromes [ J ]. Heart, 2000,83:361-366.
  • 3Clyne B ,Oishaker .IS. The C-reactive protein [J]. J gmerg Med, 1999,17 : 1019-1025.
  • 4Mold C, Gewurz H, DuClos TW. Regulation of complement activation by C-reactive protein [ J ]. Immunopharmacology, 1999,42:23-30.
  • 5Vigushin D M, Pepys M B, Hawkins PN. M etabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease[J]. J Clin Invest,1993,91 : 1351-1357.
  • 6Young B,Gleeson M, Cripps AW. C-reactive protein: a critical review [ J ]. Pathology, 1991,23:118-124.
  • 7Mulvihill NT, Foley JB. Inflammation in acute coronary syndromes[ J ]. Heart,2002,87 ( 3 ) : 201-204.
  • 8Pasceri V, Chang J, Willerson JT, et al. Modulation of c-reactive protein-mediated monocyte chemoattactant protein-induction in human endothelial cells by anti-atherosclerosis drugs [J]. Circulation, 2001 , 103 ( 21 ) : 2531-2534.
  • 9Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein [ J ]. Circulation ,2002,105 ( 16 ) : 1890-1896.
  • 10Zwaka TP, Hombach V,Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages:implications for atherosclerosis [ J ]. Circulation,2001,103(9) .1194-1197.

共引文献16

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部